SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM&C Saatchi Regulatory News (SAA)

Share Price Information for M&C Saatchi (SAA)

Share Price is delayed by 15 minutes
Get Live Data
143.00    0.00 (0.00%)
Bid:
139.50
Ask:
142.50
Spread: 3.00 (2.151%)
Market Cap: £171.23m
SAA Live PriceLast checked at - London Stock Exchange

Intraday M&C Saatchi Share Chart

M&C Saatchi - Trading Update

28 Jul 2022 07:00

RNS Number : 0024U
M&C Saatchi PLC
28 July 2022
 

M&C SAATCHI PLC

(the "Company" or "M&C Saatchi")

Trading update

 

M&C Saatchi today is pleased to announce that trading for the six months ended 30 June 2022 ("H1 2022") has continued in line with the Board's expectations.

H1 2022 net revenue growth of 10%, versus the same period in 2021, reflects a strong performance in our high growth specialisms and in the UK, Americas and Asia, and is further evidence of the successful growth strategy launched at the start of 2021. Headline profit before tax for H1 2022 is underpinned by strong new business performance and cost control, and supports the Board's confidence in achieving its expected headline profit before tax in the region of £31m for the year ending 31 December 2022 ("FY22")(1).

Net cash at 30 June 2022 was £39.5m (31 December 2021: £34.4m) and the Group's strong balance sheet provides further flexibility for satisfying the Group's future capital and investment requirements.

This strong first half trading performance is expected to continue into the second half as the Group remains focussed on accelerating the implementation of the strategy.

M&C Saatchi expects to announce its financial results for the six months to 30 June 2022 in early September.

 

Commenting on the H1 2022 performance and outlook, Moray MacLennan, Chief Executive Officer said:

"This first six months' performance has been delivered through an acceleration of the strategy, careful control of costs, and a laser like focus on client delivery. This gives us confidence for the remainder of 2022."

 

(1)As per the Company's announcement on 29 April in respect of its profit forecasts of headline profit before tax in the region of £31 million and £41 million for the years ending 31 December 2022 and 31 December 2023 respectively and subsequent confirmations of those profit forecasts in the announcement on 20 May 2022, the scheme document published on 17 June 2022 and the defence circular published on 28 June 2022.

 

For further information please call: M&C Saatchi plc

+44 (0)20-7543-4500

Gareth Davis, Chairman

Numis Securities

+44 (0)20-7260-1000

Nick Westlake, Stuart Ord, Iqra Amin, Gary Barford

 

Liberum

+44 (0)20-3100-2000

Neil Patel, Benjamin Cryer, Will King

Tim Medak, Mark Harrison, M&A

Brunswick

+44 (0)207-404-5959

Sumeet Desai, Stuart Donnelly, Kate Pope

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFILDDIDFIF
Date   Source Headline
12th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20264:16 pmRNSResult of AGM
11th Jun 20267:00 amRNSAGM Trading Update
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:07 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
29th May 20263:03 pmRNSDirector/PDMR Shareholding
29th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20261:47 pmRNSHolding(s) in Company
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSHolding(s) in Company
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSNotice of AGM and Annual Report
6th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20264:41 pmRNSDirector/PDMR Shareholding
30th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSFull Year Results
17th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSNotice of Full Year Results
19th Mar 20265:53 pmRNSHolding(s) in Company
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.